Featured Stories

Ozempic And Wegovy: What You Need To Know

Touro College of Pharmacy Experts Answer Commonly-Asked Questions About Popular Weight Loss Drugs

It seems everyone is taking Ozempic or Wegovy as a quick way to take off those pesky extra pounds. From Hollywood to suburbia, it’s become a not-so-hidden secret for those looking to lose weight. But are they safe? What are the potential side effects of long-term use? Semaglutide, the active ingredient in Ozempic and Wegovy, was originally approved to treat type 2 diabetes mellitus as Ozempic, and later approved for treatment of obesity as Wegovy. The soaring demand has resulted in worldwide medication shortages and an increase in counterfeit products. Before you start—or continue—to take the medication, here are some important facts you should know.


Ask the big questions. Be part of important conversations. Touro sponsors the Forum on Life, Culture & Society (FOLCS) which uses the arts as a catalyst for conversation and as a tool to re-examine the status quo, so we can develop ideas and together help build a better world. Join us!

FOLCS live event


The President's Report is our signature publication, spotlighting innovation, new initiatives, ground-breaking research and high achieving Touro students, faculty and alumni. You can view many of Touro's other publications on Touro Scholar. Touro University Press publishes scholarly works on the entire range of the liberal arts and sciences, with special attention to the areas of Jewish history and literature.

Touro Events

Jul 15July 15, 2024 6:30pm – 7:30pm ETBSHS/MS Occupational Therapy Information Session

School of Health Sciences

Jul 16July 16, 2024 6:30pm – 7:30pm ETDoctor of Physical Therapy Virtual Information Session

School of Health Sciences

Jul 24July 24, 2024 10:00am – 11:30am ETWhite Coat Ceremony, Harlem Class of 2028

Touro College of Osteopathic Medicine - Harlem

Around Touro

    Media Contacts

    Ellie Schlam

    Executive Director of Communications and Marketing

    (646) 565-6420

    Barbara Franklin

    Director of Communications

    (646) 565-6531